[Management of chronic viral hepatitis].

Abstract

This review highlights recent progress in the management of chronic hepatitis B, C and D. New nucleoside and nucleotide analogs have recently been approved and are currently being evaluated for the treatment of chronic hepatitis B. At the same time, resistance is becoming an increasingly common clinical problem. Efforts are currently being made to individualize treatment regimens for patients with chronic hepatitis C, with the aim of enhancing efficacy and improving tolerability. Finally, recent studies using pegylated interferon-alpha have shown promising results for the treatment of chronic hepatitis D.

• Authors: Isabelle Pache, David Mondada, Darius Moradpour, Massimiliano Fontana
• Journal: Revue medicale suisse (Rev Med Suisse) Vol. 3 Issue 95 Pg. 215, 217-8, 221-3 (Jan 24 2007) ISSN: 1660-9379 [Print] Switzerland
• Vernacular Title: Prise en charge des hépatites virales chroniques.
• PMID: 17357690 (Publication Type: English Abstract, Journal Article, Review)

Chemical References

• Antiviral Agents

Topics

• Antiviral Agents (therapeutic use)
• Chronic Disease
• Hepatitis B, Chronic (drug therapy)
• Hepatitis C, Chronic (drug therapy)
• Humans